551 related articles for article (PubMed ID: 25450256)
1. Applications for an engineered Protein-G variant with a pH controllable affinity to antibody fragments.
Bailey LJ; Sheehy KM; Hoey RJ; Schaefer ZP; Ura M; Kossiakoff AA
J Immunol Methods; 2014 Dec; 415():24-30. PubMed ID: 25450256
[TBL] [Abstract][Full Text] [Related]
2. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
3. Development of Phage-Based Antibody Fragment Reagents for Affinity Enrichment of Bacterial Immunoglobulin G Binding Proteins.
Säll A; Sjöholm K; Waldemarson S; Happonen L; Karlsson C; Persson H; Malmström J
J Proteome Res; 2015 Nov; 14(11):4704-13. PubMed ID: 26452057
[TBL] [Abstract][Full Text] [Related]
4. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antibody affinity to Japanese encephalitis virus E protein by phage display.
Hong WW; Yen YH; Wu SC
Biochem Biophys Res Commun; 2007 Apr; 356(1):124-8. PubMed ID: 17350601
[TBL] [Abstract][Full Text] [Related]
6. Protein-protein interaction regulates proteins' mechanical stability.
Cao Y; Yoo T; Zhuang S; Li H
J Mol Biol; 2008 May; 378(5):1132-41. PubMed ID: 18433770
[TBL] [Abstract][Full Text] [Related]
7. Optimal fusion of antibody binding domains resulted in higher affinity and wider specificity.
Dong J; Kojima T; Ohashi H; Ueda H
J Biosci Bioeng; 2015 Nov; 120(5):504-9. PubMed ID: 25910963
[TBL] [Abstract][Full Text] [Related]
8. The influence of antibody fragment format on phage display based affinity maturation of IgG.
Steinwand M; Droste P; Frenzel A; Hust M; Dübel S; Schirrmann T
MAbs; 2014; 6(1):204-18. PubMed ID: 24262918
[TBL] [Abstract][Full Text] [Related]
9. Design and characterization of novel dual Fc antibody with enhanced avidity for Fc receptors.
Goulet DR; Zwolak A; Williams JA; Chiu ML; Atkins WM
Proteins; 2020 May; 88(5):689-697. PubMed ID: 31702857
[TBL] [Abstract][Full Text] [Related]
10. Designing Fcabs: well-expressed and stable high affinity antigen-binding Fc fragments.
Wozniak-Knopp G; Stadlmayr G; Perthold JW; Stadlbauer K; Woisetschläger M; Sun H; Rüker F
Protein Eng Des Sel; 2017 Sep; 30(9):657-671. PubMed ID: 28981753
[TBL] [Abstract][Full Text] [Related]
11. Antibody Fab display and selection through fusion to the pIX coat protein of filamentous phage.
Tornetta M; Baker S; Whitaker B; Lu J; Chen Q; Pisors E; Shi L; Luo J; Sweet R; Tsui P
J Immunol Methods; 2010 Aug; 360(1-2):39-46. PubMed ID: 20600082
[TBL] [Abstract][Full Text] [Related]
12. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
Boehm MK; Woof JM; Kerr MA; Perkins SJ
J Mol Biol; 1999 Mar; 286(5):1421-47. PubMed ID: 10064707
[TBL] [Abstract][Full Text] [Related]
13. Engineering of Immunoglobulin Fc Heterodimers Using Yeast Surface-Displayed Combinatorial Fc Library Screening.
Choi HJ; Kim YJ; Choi DK; Kim YS
PLoS One; 2015; 10(12):e0145349. PubMed ID: 26675656
[TBL] [Abstract][Full Text] [Related]
14. An improved Protein G with higher affinity for human/rabbit IgG Fc domains exploiting a computationally designed polar network.
Jha RK; Gaiotto T; Bradbury AR; Strauss CE
Protein Eng Des Sel; 2014 Apr; 27(4):127-34. PubMed ID: 24632761
[TBL] [Abstract][Full Text] [Related]
15. The third IgG-binding domain from streptococcal protein G. An analysis by X-ray crystallography of the structure alone and in a complex with Fab.
Derrick JP; Wigley DB
J Mol Biol; 1994 Nov; 243(5):906-18. PubMed ID: 7966308
[TBL] [Abstract][Full Text] [Related]
16. Transfer of engineered biophysical properties between different antibody formats and expression systems.
Schaefer JV; Plückthun A
Protein Eng Des Sel; 2012 Oct; 25(10):485-506. PubMed ID: 22763265
[TBL] [Abstract][Full Text] [Related]
17. Engineering antibodies for stability and efficient folding.
Honegger A
Handb Exp Pharmacol; 2008; (181):47-68. PubMed ID: 18071941
[TBL] [Abstract][Full Text] [Related]
18. Combining somatic mutations present in different in vivo affinity-matured antibodies isolated from immunized Lama glama yields ultra-potent antibody therapeutics.
Klarenbeek A; Blanchetot C; Schragel G; Sadi AS; Ongenae N; Hemrika W; Wijdenes J; Spinelli S; Desmyter A; Cambillau C; Hultberg A; Kretz-Rommel A; Dreier T; De Haard HJ; Roovers RC
Protein Eng Des Sel; 2016 Apr; 29(4):123-33. PubMed ID: 26945588
[TBL] [Abstract][Full Text] [Related]
19. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
[TBL] [Abstract][Full Text] [Related]
20. Correlation between CD16a binding and immuno effector functionality of an antigen specific immunoglobulin Fc fragment (Fcab).
Kainer M; Antes B; Wiederkum S; Wozniak-Knopp G; Bauer A; Rüker F; Woisetschläger M
Arch Biochem Biophys; 2012 Oct; 526(2):154-8. PubMed ID: 22634259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
